S100B-RAGE dependent VEGF secretion by cardiac myocytes induces myofibroblast proliferation

Journal of Molecular and Cellular Cardiology

Volumn 52, Issue 2, 2012, Pages 464-473

  Tsoporis, James N ^a   Izhar, Shehla ^a   Proteau, Gerald ^a   Slaughter, Graham ^a   Parker, Thomas G ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

ERK1 2; Myocardial infarction; Myofibroblasts; S100B; VEGF; VEGFR2

Indexed keywords

ADVANCED GLYCATION END PRODUCT RECEPTOR; ALPHA SMOOTH MUSCLE ACTIN; CAFFEIC ACID PHENETHYL ESTER; COLLAGEN TYPE 1; COLLAGEN TYPE 4; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE 3; PROTEIN S100B; PROTEIN TYROSINE KINASE; VASCULOTROPIN; VASCULOTROPIN RECEPTOR 1; VASCULOTROPIN RECEPTOR 2;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY WEIGHT; CELL CULTURE; CELL PROLIFERATION; CONTROLLED STUDY; DELETION MUTANT; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION; GENETIC TRANSFECTION; HEART INFARCTION; HEART LEFT VENTRICLE DP-DT; HEART LEFT VENTRICLE ENDDIASTOLIC PRESSURE; HEART LEFT VENTRICLE PRESSURE; HEART LEFT VENTRICLE SYSTOLIC PRESSURE; HEART MUSCLE CELL; HEART RATE; HEART VENTRICLE HYPERTROPHY; HEART VENTRICLE REMODELING; MEAN ARTERIAL PRESSURE; MYOFIBROBLAST; NEWBORN; NONHUMAN; PARACRINE SIGNALING; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; PROTEIN SECRETION; RAT; SCAR FORMATION; UPREGULATION;

ANIMALS; CELL PROLIFERATION; FIBROBLASTS; HEMODYNAMICS; HUMANS; MYOCARDIAL INFARCTION; MYOCYTES, CARDIAC; MYOFIBROBLASTS; NERVE GROWTH FACTORS; NF-KAPPA B; PHOSPHORYLATION; PRIMARY CELL CULTURE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, IMMUNOLOGIC; S100 PROTEINS; SIGNAL TRANSDUCTION; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-2; VENTRICULAR REMODELING;

RATTUS;

EID: 84855995968     PISSN: 00222828     EISSN: 10958584     Source Type: Journal    
DOI: 10.1016/j.yjmcc.2011.08.015     Document Type: Article

References (47)

1. Pfeffer M.A., Braunwald E. Ventricular remodeling after myocardial infarction: experimental observations and clinical implications. Circulation 1990, 81:1161-1172.
2. Mnabe I., Shindo T., Nagai R. Gene expression in fibroblasts and fibrosis. Involvement in cardiac hypertrophy. Circ Res 2002, 91:1103-1113.
3. Tsoporis J.N., Marks A., Haddad A., Dawood F., Liu P.P., Parker T.G. S100B expression modulates left ventricular remodeling after myocardial infarction in mice. Circulation 2005, 111:598-606.
4. Donato R. Intracellular and extracellular roles of S100 proteins. Microsc Res Tech 2003, 60:540-551.
5. 1-adrenergic induction of the hypertrophic phenotype in cardiac myocytes. J Biol Chem 1997, 272:31915-31921.
6. Tsoporis J.N., Marks A., Kahn H.J., Butany J.W., Liu P.P., O'Hanlon D., et al. Inhibition of norepinephrine-induced cardiac hypertrophy in S100B transgenic mice. J Clin Invest 1998, 102:1609-1616.
7. 1-adrenergic stimulation in cardiac myocytes. Am J Physiol 2003, 284:H193-H203.
8. Yan S.F., Berile G.R., D'Agati V., Du Yan S., Ramasamy R., Schmidt A.M. The biology of RAGE and its ligands: uncovering mechanisms at the heart of diabetes and its complications. Curr Diab Rep 2007, 2:146-153.
9. Tsoporis J.N., Izhar S., Leong-Poi H., Desjardins J.F., Huttunen H.J., Parker T.G. S100B interaction with the receptor for advanced glycation end products (RAGE): a novel receptor-mediated mechanism for myocyte apoptosis postinfarction. Circ Res 2010, 106:93-101.
10. Ma W., Lee S.E., Guo J., Qu W., Hudson B.I., Schmidt A.M., et al. RAGE ligand upregulation of VEGF secretion in ARPE-19 cells. Invest Ophthalmol Vis Sci 2007, 48:1355-1361.
11. 165 to its receptors. Biochem Biophys Res Commun 1994, 203:1339-1347.
12. Pertovaara L., Kaipainen A., Mustonen T., Orpana A., Ferrara N., Saksela O., et al. Vascular endothelial growth factor is induced in response to transforming growth factor-beta in fibroblastic and epithelial cells. J Biol Chem 1994, 269:6271-6274.
13. Stavri G., Hong T.Y., Zachary I.C., Breir G., Baskerville P.A., Yla-Herttuala S., et al. Hypoxia and platelet-derived growth factor-BB synergistically upregulate expression of VEGF in vascular smooth muscle cells. FEBS Lett 1995, 358:311-315.
14. Lee H.S., Wolf P.L., Escuredo R., Deutsch R., Jamieson S.W., Thistlewaite P.A. Early expression of angiogenesis factors in acute myocardial ischemia and infarction. N Engl Med 2000, 342:626-633.
15. Goto F., Goto K., Weindel K., Folkman J. Synergistic effects of vascular endothelial growth factor and basic fibroblast growth factor on the proliferation and cord formation of bovine capillary endothelial cells within collagen gels. Lab Invest 1993, 69:508-514.
16. Xiao Z., Kong Y., Yang S., Li M., Wen J., Li J. Upregulation of Flk-1 by bFGF via the ERK pathway is essential for VEGF-mediated promotion of neural stem cell proliferation. Cell Res 2007, 17:73-79.
17. Banai S., Jaklitsch M.T., Shou M., Lazarous D.F., Scheinowitz M., Biro S. Angiogenic-induced enhancement of collateral blood flow to ischemic myocardium by VEGF in dogs. Circulation 1994, 89:2183-2189.
18. Takeshita S., Zheng L.P., Brogi E., Kearney M., Pu L.Q., Bunting S., et al. Therapeutic angiogenesis. A single intraarterial bolus of vascular endothelial growth factor augments revascularization in a rabbit ischemic hind limb model. J Clin Invest 1994, 93:6662-6670.
19. Waltenberger J., Claesson-Welsh L., Siegbahn A., Shibuya M., Heldin C.H. Different signal transduction properties of KDR and Flt1, two receptors for VEGF. J Biol Chem 1994, 269:26988-26995.
20. Olsson A.K., Dimberg A., Kreuger J., Claesson-Welsh L. VEGF receptor signaling-in control of vascular function. Nat Rev Mol Cell Biol 2006, 7:359-371.
21. Swendeman S., Mendelson K., Weskamp G., Horiuchi K., Deutsch U., Scherle P., et al. VEGF-A stimulates ADAM17-dependent shedding of VEGFR2 and crosstalk between VEGFR2 and ERK signaling. Circ Res 2008, 101:916-918.
22. Minchenko A., Bauer T., Salceda S., Caro J. Hypoxic stimulation of VEGF in vitro and in vivo. Lab Invest 1994, 71:374-379.
23. Ferrara N. Role of vascular endothelial growth factor in regulation of physiological angiogenesis. Am J Physiol Cell Physiol 2001, 280:C1358-C1366.
24. Toyota E., Writier D.C., Brock T., Titman E., Kolz C., O'Malley P., et al. Vascular endothelial growth factor is required for coronary collateral growth in the rat. Circulation 2005, 112:2108-2113.
25. Seko Y., Tobe K., Ueki K., Kadowaki T., Yazaki Y. Hypoxia and hypoxia/reoxygenation activate Raf-1, mitogen-activated protein kinase kinase, mitogen-activated protein kinases and S6 kinase in cultured rat cardiac myocytes. Circ Res 1998, 78:82-90.
26. Rehn T.A., Borge B.A., Lunde P.K., Munkvik M., Sneve M.L., Grondahl F., et al. Temporary fatigue and altered extracellular matrix in skeletal muscle during progression of heart failure in rats. Am J Physiol Regul Integr Comp Physiol 2009, 297:R26-R33.
27. Wu G., Rana J.S., Wykrzykowska J., Du Z., Ke Q., Kang P., et al. Exercise-induced expression of VEGF and salvation of myocardium in the early stage of myocardial infarction. Am J Physiol Heart Circ Physiol 2009, 296:H389-H395.
28. Chintalgattu V., Nair D.M., Katwa L.C. Cardiac myofibroblasts: a novel source of vascular endothelial growth factor (VEGF) and its receptors Flt-1 and KDR. J Mol Cell Cardiol 2003, 35:277-286.
29. Long C.S., Henrich C.J., Simpson P.C. A growth factor for cardiac myocytes is produced by cardiac nonmyocytes. Cell Regul 1991, 2:1081-1085.
30. Hao J., Wang B., Jones S.C., Jassal D.S., Dixon I.M. Interaction between angiotensin II and Smad proteins in fibroblasts in failing heart and in vitro. Am J Physiol Heart Circ Physiol 2000, 279:H3020-H3030.
31. Santiago J.J., Dangerfield A.L., Rattan S.G., Bathe K.L., Cunnington R.H., Raizman J.E., et al. Cardiac fibroblast to myofibroblast differentiation in vivo and in vitro: expression of focal adhesion components in neonatal and adult rat ventricular myofibroblasts. Dev Dyn 2010, 239:1573-1584.
32. Tsoporis J.N., Izhar S., Parker T.G. Expression of S100A6 in cardiac myocytes limits apoptosis induced by tumor necrosis factor-alpha. J Biol Chem 2008, 283:30174-30183.
33. Bianchi R., Kastrisianaki E., Giambanco I., Rosario R. S100B protein stimulates microglia migration via RAGE-dependent up-regulation of chemokine expression and release. J Biol Chem 2010, 286:7214-7226.
34. Mazzini G.S., Schaf D., Oliveira A.R., Goncalves C.A., Bello-Klein A., Bordignon S., et al. The ischemic heart rat heart releases S100B. Life Sci 2005, 77:882-889.
35. Ladoux A., Frelin C. Hypoxia is a strong inducer of vascular endothelial growth factor mRNA expression in the heart. Biochem Biophys Res Commun 1993, 195:1005-1010.
36. Huttunen H.J., Kuja-Panula J., Sorci G., Agneletti A.L., Donato R., Rauvala H. Coregulation of neurite outgrowth and cell survival by amphoterin and S100 proteins through RAGE activation. J Biol Chem 2000, 275:40096-40105.
37. Leclerc E., Fritz G., Weibel M., Heizmann C.W., Galichet A. S100B and S100A6 differentially modulate cell survival by interacting with distinct RAGE immunoglobulin domains. J Biol Chem 2007, 282:31317-31331.
38. Karpanen T., Bry M., Ollila H.A., Seppänen-Laakso T., Liimatta E., Leskinen H., et al. Overexpression of VEGF-B in mouse heart alters cardiac lipid metabolism and induces myocardial hypertrophy. Circ Res 2008, 103:1018-1026.
39. Tirziu D., Chorianopoulos E., Moodie K.L., Palac R.T., Zhuang Z.W., Tjwa M., et al. Myocardial hypertrophy in the absence of external stimuli is induced by angiogenesis in mice. J Clin Invest 2007, 117:3188-3197.
40. Zentilin L., Puligadda U., Lionetti V., Zacchigna S., Collesi C., Pattarini L., et al. Cardiomyocyte VEGFR-1 activation by VEGF-B induces compensatory hypertrophy and preserves cardiac function after myocardial infarction. FASEB J 2010, 24:1467-1478.
41. Zhou Y., Bourcy K., Kang Y.J. Copper-induced regression of cardiomyocyte hypertrophy is associated with enhanced vascular endothelial growth factor receptor-1 signalling pathway. Cardiovasc Res 2009, 84:54-63.
42. Zhou Y., Jiang Y., Kang Y.J. Copper reverses cardiomyocyte hypertrophy through vascular endothelial growth factor-mediated reduction in the cell size. J Mol Cell Cardiol 2008, 45:106-117.
43. Hiratsuka S., Minowa O., Kuno J., Noda T., Shibuya M. Flt-1 lacking the tyrosine kinase domain is sufficient for normal development and angiogenesis in mice. Proc Natl Acad Sci USA 1998, 4:9349-9354.
44. Millauer B., Shawver L.K., Plate K.H., Risau W., Ullrich A. Glioblastoma growth inhibited in vivo by a dominant-negative Flk-1 mutant. Nature 1994, 367:576-579.
45. Shalaby F., Rossant J., Yanaguchi T.P., Gertsenstein M., Wu X.F., Breitman M.L., et al. Failure of blood-island formation and vasculogenesis in Flk-1 deficient mice. Nature 1995, 376:62-66.
46. Bueno O.F., Molkentin J.D. Involvement of extracellular signal-regulated kinases 1/2 in cardiac hypertrophy and cell death. Circ Res 2002, 91:776-781.
47. Ac Nag, Cheng M. Biochemical evidence for cellular dedifferentiation in adult rat cardiac muscle cells in culture: expression of myosin isozymes. Biochem Biophys Res Commun 1986, 137:855-862.